SCHEMBL25663123

SCHEMBL25663123

c1ccc2sc(-c3ccc(N(c4ccc(-c5nc6ccccc6s5)cc4)c4ccc(-c5ncnc6sc7ccccc7c56)cc4)cc3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 5/20 0.50
▸ RAB9A P51151 5/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MMP9 P14780 2/20 0.44
▸ MMP8 P22894 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PAX8 Q06710 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TNF P01375 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663108 0.85 NPC1 (0.40) APPRAB9ANPC1KDM4EGAA
SCHEMBL25663098 0.85 RAB9A (0.39) APPRAB9ANPC1KDM4EGAA
SCHEMBL25663113 0.84 PIK3CD (0.33) APPKDM4EMAPTALDH1A1LMNA
SCHEMBL25663181 0.83 APP (0.51) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663101 0.83 PIK3CA (0.48) EGFRSRCKDR
SCHEMBL25663166 0.82 APP (0.50) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663109 0.82 TGFBR1 (0.39) APPKDM4EMAPTALDH1A1MEN1
SCHEMBL25663107 0.82 CYP1A2 (0.47) APPRAB9ANPC1KDM4EGLA
SCHEMBL25663099 0.81 NPC1 (0.39) RAB9ANPC1KDM4E
SCHEMBL25663276 0.80 APP (0.52) APPRAB9ANPC1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 APP 2850/4885RAB9A 2198/4885NPC1 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback